Form 3 - Initial statement of beneficial ownership of securities

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

BeyondSpring (NASDAQ:BYSI)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more BeyondSpring Charts.

BeyondSpring (NASDAQ:BYSI)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more BeyondSpring Charts.

BeyondSpring Inc News

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 1 January 2025 (3 days ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

BeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting
Tuesday 12 November 2024 (2 months ago) • GlobeNewswire Inc.

BeyondSpring Presents Final Data Analysis of DUBLIN-3 Phase 3 Study in 2L/3L EGFR Wild-type NSCLC at ESMO Congress 2024
Monday 16 September 2024 (4 months ago) • GlobeNewswire Inc.

BeyondSpring Delivers Oral Presentation at ISLAC 2024 World Conference on Lung Cancer of its Lead Anti-Cancer Asset Plinabulin Showcasing Positive Final Phase 3 Data in 2L/3L NSCLC EGFR Wild-Type with Concurrent Publication in the Lancet Respiratory Medici
Tuesday 10 September 2024 (4 months ago) • GlobeNewswire Inc.

BeyondSpring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During ESMO Congress 2024 Showcasing its Lead Anti-Cancer Asset, Plinabulin
Tuesday 3 September 2024 (4 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 30 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 6 August 2024 (5 months ago) • Edgar (US Regulatory)

SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications
Tuesday 6 August 2024 (5 months ago) • GlobeNewswire Inc.

Form F-3 - Registration statement by foreign private issuers
Thursday 13 June 2024 (7 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 13 June 2024 (7 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 12 June 2024 (7 months ago) • Edgar (US Regulatory)

More BeyondSpring Inc News Articles

Verizon Communications

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions